Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-25-072838
Filing Date
2025-08-07
Accepted
2025-08-07 08:44:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5464
  Complete submission text file 0001213900-25-072838.txt   6941
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Subject) CIK: 0001723980 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90926 | Film No.: 251191841
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BLK 264 JURONG EAST STREET 24 #12-521 SINGAPORE Singapore 600264
Business Address
TAN SOO SENG (Filed by) CIK: 0002078261 (see all company filings)

Type: SCHEDULE 13G